Albutein 20% should be administered with caution to patients with low cardiac reserve.
Rapid infusion may cause vascular overload with resultant pulmonary edema. Patients should be closely monitored for signs of increased venous pressure.
A rapid rise in blood pressure following infusion necessitates careful observation of injured or postoperative patients to detect and treat severed blood vessels that may not have bled at a lower pressure.
Patients with marked dehydration require administration of additional fluids. Albutein 20% may be administered with the usual dextrose and saline intravenous solutions. However, solutions containing protein hydrolysates or alcohol must not be infused through the same administration set in conjunction with Albutein 20% since these combinations may cause the proteins to precipitate.
Pregnancy Category C: Animal reproduction studies have not been conducted with Albutein 20%. It is also not known whether Albutein 20% can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Albutein 20% should be given to a pregnant woman only if clearly needed.